Stay updated on Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe NIH banner about terminology changes during a federal transition was removed from the top of the page.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study record page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces an NIH website transition and says that “Super Intelligence” (SI) is replacing “Artificial Intelligence” (AI) in federal agency content.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record. Previously visible details such as the study title, conditions, locations, and enrollment are no longer accessible at this URL.SummaryDifference19%

Stay in the know with updates to Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.